# Denovo Biopharma LLC clinical trials: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials with Denovo Biopharma LLC as lead sponsor, 0 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Denovo Biopharma LLC: 22 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/denovo-biopharma-llc

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 0
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 9, 2021 | NCT05113771 | A Biomarker-Guided, Randomized, Placebo-Controlled Efficacy and Safety Study of Liafensine in Patients With TRD | Denovo Biopharma LLC | Phase 2 | Completed | Treatment Resistant Depression | 197 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05113771) |
| December 14, 2018 | NCT03776071 | A Trial of Enzastaurin Plus Temozolomide During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma With or... | Denovo Biopharma LLC | Phase 3 | Completed | Glioblastoma | 260 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03776071) |
| August 28, 2017 | NCT03263026 | Study to Assess Enzastaurin + R-CHOP in Subjects With DLBCL With the Genomic Biomarker DGM1™ | Denovo Biopharma LLC | Phase 3 | Completed | Diffuse Large B-Cell Lymphoma | 256 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03263026) |
| August 7, 2012 | NCT01659177 | A Study of LY2140023 in Healthy Participants | Denovo Biopharma LLC | Phase 1 | Withdrawn | Healthy Participants | 0 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01659177) |
| July 11, 2012 | NCT01637142 | A Study of LY2140023 in Healthy Participants | Denovo Biopharma LLC | Phase 1 | Completed | Healthy Participants | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01637142) |
| May 31, 2012 | NCT01609218 | A Study of LY2140023 in Healthy Participants | Denovo Biopharma LLC | Phase 1 | Completed | Healthy Volunteer Study | 27 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01609218) |
| May 25, 2012 | NCT01606436 | A Study Measuring Effect of LY2140023 (Pomaglumetad Methionil) on Electrocardiographs in Participants With Schizophrenia | Denovo Biopharma LLC | Phase 1 | Completed | Schizophrenic Disorders | 86 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01606436) |
| May 4, 2012 | NCT01591330 | A Study of LY2140023 in Healthy Males and Females | Denovo Biopharma LLC | Phase 1 | Completed | Healthy Volunteers | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01591330) |
| December 7, 2011 | NCT01487083 | A Long-Term Safety Study of Pomaglumetad Methionil in Schizophrenia | Denovo Biopharma LLC | Phase 3 | Terminated | Schizophrenia | 129 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01487083) |
| November 21, 2011 | NCT01475136 | A Study of LY2140023 in Hepatically-Impaired Participants | Denovo Biopharma LLC | Phase 1 | Completed | Hepatic Insufficiency | 37 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01475136) |
| October 17, 2011 | NCT01452919 | A Physical Dependence Study in Schizophrenia | Denovo Biopharma LLC | Phase 3 | Completed | Schizophrenia | 123 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01452919) |
| September 26, 2011 | NCT01440478 | The Effects of Urinary pH Changes on an Investigational Compound in Healthy Subjects | Denovo Biopharma LLC | Phase 1 | Completed | Healthy Subjects | 29 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01440478) |
| May 16, 2011 | NCT01354353 | A Study of Safety and Tolerability in Subjects With Schizophrenia | Denovo Biopharma LLC | Phase 1 | Completed | Schizophrenia | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01354353) |
| April 4, 2011 | NCT01328093 | A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients | Denovo Biopharma LLC | Phase 3 | Terminated | Schizophrenia | 678 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01328093) |
| March 3, 2011 | NCT01307800 | A Study of LY2140023 in Patients With Schizophrenia | Denovo Biopharma LLC | Phase 3 | Terminated | Schizophrenia | 567 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01307800) |
| May 25, 2010 | NCT01129674 | A Long-Term, Open-Label, Study on Schizophrenia | Denovo Biopharma LLC | Phase 2/3 | Terminated | Schizophrenia | 560 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01129674) |
| May 18, 2010 | NCT01125358 | A Study in Schizophrenic Patients | Denovo Biopharma LLC | Phase 2 | Terminated | Schizophrenia | 82 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01125358) |
| March 15, 2010 | NCT01086748 | A Comparator Study of LY2140023 Versus Placebo in Schizophrenia Patients | Denovo Biopharma LLC | Phase 2 | Completed | Schizophrenia | 1,134 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01086748) |
| January 20, 2010 | NCT01052103 | A Study of LY2140023 in Schizophrenia Patients With Prominent Negative Symptoms | Denovo Biopharma LLC | Phase 2 | Completed | Schizophrenia | 167 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01052103) |
| February 16, 2009 | NCT00845026 | A Safety Study Comparing LY2140023 to Atypical Antipsychotic Standard Treatment in Schizophrenic Patients | Denovo Biopharma LLC | Phase 2 | Completed | Schizophrenia | 261 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00845026) |
| August 27, 2007 | NCT00520923 | A Study for Participants With Schizophrenia | Denovo Biopharma LLC | Phase 2 | Completed | Schizophrenia | 669 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00520923) |
| September 8, 2005 | NCT00149292 | Study of LY2140023 in Schizophrenia Comparing LY2140023, Olanzapine, and Placebo | Denovo Biopharma LLC | Phase 2 | Completed | Schizophrenia | 195 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT00149292) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 8 |
| Phase 2 | 7 |
| Phase 2/3 | 1 |
| Phase 3 | 6 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 16 |
| Terminated | 5 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Schizophrenia | 13 |
| Depressive Disorder, Treatment-Resistant | 1 |
| Hepatic Insufficiency | 1 |
| Lymphoma, Large B-Cell, Diffuse | 1 |
| Lymphoma | 1 |
| Lymphoma, Non-Hodgkin | 1 |
| Glioblastoma | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Soup restaurants in the United States](https://specstream.ai/data/businesses/soup-restaurants/united-states)
- [Orthotics providers in the United States](https://specstream.ai/data/businesses/orthotics-providers/united-states)
- [HVAC suppliers in the United States](https://specstream.ai/data/businesses/hvac-suppliers/united-states)
- [Dumpling restaurants in the United States](https://specstream.ai/data/businesses/dumpling-restaurants/united-states)
- [Basque restaurants in the United States](https://specstream.ai/data/businesses/basque-restaurants/united-states)
- [Urgent care clinics in the United States](https://specstream.ai/data/businesses/urgent-care-clinics/united-states)
